Treatment and outcome of recurrent osteosarcoma: Experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy
Open Access
- 1 January 2005
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 44 (7), 748-755
- https://doi.org/10.1080/02841860500327503
Abstract
The pattern of relapse, treatment and final outcome of 235 patients with osteosarcoma of the extremity who relapsed after neoadjuvant treatments performed between 1986 and 1998 at a single institution is reported. The 235 relapses were treated by surgery, surgery plus second line chemotherapy, and only second line chemotherapy or radiotherapy. The 5-year post-relapse-event-free-survival (PREFS) was 27.6% and the post-relapse-overall-survival (PROS) 28.7%. All 69 patients who are presently alive and free of disease were treated by surgery, alone or combined with chemotherapy. None of patients treated only by chemotherapy or radiotherapy survived. We conclude that it is possible to obtain prolonged survival and cure in about 1/4 of relapsing osteosarcoma patients with aggressive treatments. The complete removal of the recurrence is essential for outcome, while the role of the association of second-line chemotherapy remains to be defined.Keywords
This publication has 25 references indexed in Scilit:
- Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)Journal of Clinical Oncology, 2005
- Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapyCancer, 2003
- Presurgical Chemotherapy Compared With Immediate Surgery and Adjuvant Chemotherapy for Nonmetastatic Osteosarcoma: Pediatric Oncology Group Study POG-8651Journal of Clinical Oncology, 2003
- Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological respondersEuropean Journal of Cancer, 2003
- High Dose Ifosfamide in Combination with High Dose Methotrexate, Adriamycin and Cisplatin in the Neoadjuvant Treatment of Extremity Osteosarcoma: Preliminary Results of an Italian Sarcoma Group/Scandinavian Sarcoma Group Pilot StudyJournal of Chemotherapy, 2002
- Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocolEuropean Journal of Cancer, 2001
- Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapyEuropean Journal of Cancer, 2001
- Metastasectomy for sarcomatous pediatric histologies: Results and prognostic factorsThe Annals of Thoracic Surgery, 1995
- Patterns of Recurrence After Resection of Osteosarcoma of the ExtremityArchives of Surgery, 1989
- Improved survival in children with osteosarcoma following resection of pulmonary metastasesJournal of Pediatric Surgery, 1982